paclitaxel has been researched along with Keratoderma Blennorrhagicum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cawthon, CV; Christians, U; Erwin, M; Fedor, N; Geary, RL; Goel, E; Rayl, T; Register, TC; Saul, J; Schaff, C; Wilson, O; Yazdani, SK | 1 |
| Bosch, RJ; Herrera, E; López, N; Tejera, A | 1 |
2 other study(ies) available for paclitaxel and Keratoderma Blennorrhagicum
| Article | Year |
|---|---|
Pre-Clinical Investigation of Keratose as an Excipient of Drug Coated Balloons.
Topics: Angioplasty, Balloon; Animals; Antineoplastic Agents; Cardiovascular Agents; Coated Materials, Biocompatible; Drug Carriers; Drug Delivery Systems; Drug Evaluation, Preclinical; Immunohistochemistry; Keratosis; Paclitaxel; Peripheral Arterial Disease | 2020 |
[Onycholysis with hyponychium exudate secondary to chemotherapy with paclitaxel and capecitabine].
Topics: Adult; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Astringents; Breast Neoplasms; Capecitabine; Deoxycytidine; Exudates and Transudates; Female; Fluorouracil; Hallux; Humans; Keratosis; Mupirocin; Nail Diseases; Ointments; Paclitaxel; Time Factors; Treatment Outcome; Zinc Sulfate | 2006 |